Published in Gastroenterology on September 01, 2005
Long-term outcome of Helicobacter pylori-negative idiopathic bleeding ulcers: a prospective cohort study. Gastroenterology (2005) 1.56
Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol (2008) 7.65
Pancreatic endocrine tumors: expression profiling evidences a role for AKT-mTOR pathway. J Clin Oncol (2009) 2.94
Thyroxine in goiter, Helicobacter pylori infection, and chronic gastritis. N Engl J Med (2006) 2.75
Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization. Endocr Relat Cancer (2005) 2.24
Rapid and sustained relief from the symptoms of carcinoid syndrome: results from an open 6-month study of the 28-day prolonged-release formulation of lanreotide. Neuroendocrinology (2004) 2.16
Risk factors for intraductal papillary mucinous neoplasm (IPMN) of the pancreas: a multicentre case-control study. Am J Gastroenterol (2013) 2.11
Radiolabelled somatostatin analogue treatment in gastroenteropancreatic neuroendocrine tumours: factors associated with response and suggestions for therapeutic sequence. Eur J Nucl Med Mol Imaging (2013) 2.06
Acute fulminant hepatitis E virus genotype 3e infection: description of the first case in Europe. Scand J Infect Dis (2014) 2.03
Effect of chronic hypergastrinemia on human enterochromaffin-like cells: insights from patients with sporadic gastrinomas. Gastroenterology (2002) 1.62
Proteomic analysis of chronic pancreatitis and pancreatic adenocarcinoma. Gastroenterology (2005) 1.61
HCV-positive status and hepatitis flares in patients with B-cell non-Hodgkin's lymphoma treated with rituximab-containing regimens. Dig Liver Dis (2010) 1.58
Alteration of local microflora and α-defensins hyper-production in colonic adenoma mucosa. J Clin Gastroenterol (2011) 1.57
Occurrence and risk factors for autoimmune thyroid disease in patients with atrophic body gastritis. Am J Med (2008) 1.56
Metastatic and locally advanced pancreatic endocrine carcinomas: analysis of factors associated with disease progression. J Clin Oncol (2011) 1.42
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: biochemical markers. Neuroendocrinology (2009) 1.42
Gastric carcinoid in the absence of atrophic body gastritis and with low Ki67 index: a clinical challenge. Scand J Gastroenterol (2014) 1.38
Pernicious anemia: new insights from a gastroenterological point of view. World J Gastroenterol (2009) 1.22
Training with a computer-based simulator achieves basic manual skills required for upper endoscopy: a randomized controlled trial. Gastrointest Endosc (2004) 1.16
Celiac disease and CFTR mutations in patients with chronic asymptomatic pancreatic hyperenzymemia. Am J Gastroenterol (2013) 1.13
Consensus guidelines on severe acute pancreatitis. Dig Liver Dis (2015) 1.12
Role of the gut barrier in acute pancreatitis. J Clin Gastroenterol (2012) 1.11
Lansoprazole-induced microscopic colitis: an increasing problem? Results of a prospecive case-series and systematic review of the literature. Dig Liver Dis (2010) 1.10
Nonfunctioning pancreatic endocrine tumors: a multicenter clinical study. Am J Gastroenterol (2003) 1.10
Gastroenteropancreatic (neuro)endocrine neoplasms: the histology report. Dig Liver Dis (2011) 1.09
Type I gastric carcinoids: a prospective study on endoscopic management and recurrence rate. Neuroendocrinology (2011) 1.08
Can patient characteristics predict the outcome of endoscopic evaluation of iron deficiency anemia: a multiple logistic regression analysis. Gastrointest Endosc (2004) 1.08
The eradication of Helicobacter pylori is affected by body mass index (BMI). Obes Surg (2008) 1.07
Poorly differentiated carcinomas of the foregut (gastric, duodenal and pancreatic). Neuroendocrinology (2007) 1.07
Chromogranin A as a marker of neuroendocrine neoplasia: an Italian Multicenter Study. Endocr Relat Cancer (2007) 1.07
Well-differentiated gastric tumors/carcinomas. Neuroendocrinology (2007) 1.06
Proton pump inhibitor therapy and potential long-term harm. Curr Opin Endocrinol Diabetes Obes (2014) 1.06
Risk for gastric neoplasias in patients with chronic atrophic gastritis: a critical reappraisal. World J Gastroenterol (2012) 1.06
Ki-67 grading of nonfunctioning pancreatic neuroendocrine tumors on histologic samples obtained by EUS-guided fine-needle tissue acquisition: a prospective study. Gastrointest Endosc (2012) 1.05
Biological targeted therapies in patients with advanced enteropancreatic neuroendocrine carcinomas. Cancer Treat Rev (2010) 1.05
Src family kinase activity regulates adhesion, spreading and migration of pancreatic endocrine tumour cells. Endocr Relat Cancer (2007) 1.03
Italian consensus guidelines for chronic pancreatitis. Dig Liver Dis (2010) 1.02
Malignant pancreatic neuroendocrine tumour: lymph node ratio and Ki67 are predictors of recurrence after curative resections. Eur J Cancer (2011) 1.02
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: chemotherapy in patients with neuroendocrine tumors. Neuroendocrinology (2009) 1.01
Artificial neural networks in the recognition of the presence of thyroid disease in patients with atrophic body gastritis. World J Gastroenterol (2008) 0.96
Risk factors for disease progression in advanced jejunoileal neuroendocrine tumors. Neuroendocrinology (2011) 0.96
Role of resection of the primary pancreatic neuroendocrine tumour only in patients with unresectable metastatic liver disease: a systematic review. Neuroendocrinology (2011) 0.95
Genetic susceptibility to pancreatic cancer and its functional characterisation: the PANcreatic Disease ReseArch (PANDoRA) consortium. Dig Liver Dis (2012) 0.95
Extragastric manifestations of Helicobacter pylori infection -- other Helicobacters. Helicobacter (2007) 0.95
Clinicopathological features of pancreatic endocrine tumors: a prospective multicenter study in Italy of 297 sporadic cases. Am J Gastroenterol (2010) 0.94
Expression of the proto-oncogene c-KIT in normal and tumor tissues from colorectal carcinoma patients. Int J Colorectal Dis (2004) 0.94
A prospective study of gastric carcinoids and enterochromaffin-like cell changes in multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: identification of risk factors. J Clin Endocrinol Metab (2008) 0.93
Micronutrients (Other than iron) and Helicobacter pylori infection: a systematic review. Helicobacter (2012) 0.93
Lack of specific association between gastric autoimmunity hallmarks and clinical presentations of atrophic body gastritis. World J Gastroenterol (2005) 0.93
Appropriateness of the indication for colonoscopy: is the endoscopist the 'gold standard'? J Clin Gastroenterol (2012) 0.93
Cost-effectiveness of endoscopic surveillance for gastric intestinal metaplasia. Helicobacter (2010) 0.91
Treatment of diverticular disease of the colon and prevention of acute diverticulitis: a systematic review. Dis Colon Rectum (2011) 0.91
Reassessment of intrinsic factor and parietal cell autoantibodies in atrophic gastritis with respect to cobalamin deficiency. Am J Gastroenterol (2009) 0.90
Molecular pathogenesis of neuroendocrine tumors: implications for current and future therapeutic approaches. Clin Cancer Res (2013) 0.90
Somatostatin receptor subtypes 2 and 5 are associated with better survival in well-differentiated endocrine carcinomas. Neuroendocrinology (2008) 0.89
Gastric and duodenal neuroendocrine tumours. Best Pract Res Clin Gastroenterol (2012) 0.89
Gastric neuroendocrine tumors. Neuroendocrinology (2004) 0.89
Molecular pathology and genetics of pancreatic endocrine tumours. J Mol Endocrinol (2012) 0.89
Different patterns of 11q allelic losses in digestive endocrine tumors. Hum Pathol (2002) 0.88
Use and safety perception of herbal remedies in patients with liver/biliary tract disorders: an Italian study. J Clin Gastroenterol (2010) 0.88
Simultaneous intraductal papillary neoplasms of the bile duct and pancreas treated with chemoradiotherapy. World J Gastrointest Oncol (2012) 0.88
Low prevalence of idiopathic peptic ulcer disease: an Italian endoscopic survey. Dig Liver Dis (2010) 0.88
Exocrine pancreatic insufficiency in adults: a shared position statement of the Italian Association for the Study of the Pancreas. World J Gastroenterol (2013) 0.88
Probiotics and the incidence of colorectal cancer: when evidence is not evident. Dig Liver Dis (2006) 0.88
Familial pancreatic cancer in Italy. Risk assessment, screening programs and clinical approach: a position paper from the Italian Registry. Dig Liver Dis (2010) 0.88
Early manifestations of gastric autoimmunity in patients with juvenile autoimmune thyroid diseases. J Clin Endocrinol Metab (2004) 0.88
Occurrence of gastric cancer and carcinoids in atrophic gastritis during prospective long-term follow up. Scand J Gastroenterol (2015) 0.87
Repeated transabdominal ultrasonography is a simple and accurate strategy to diagnose a biliary etiology of acute pancreatitis. Pancreas (2014) 0.87
Role of noninvasive tests (C-urea breath test and stool antigen test) as additional tools in diagnosis of Helicobacter pylori infection in patients with atrophic body gastritis. Helicobacter (2004) 0.87
Endocrine tumours of the stomach. Best Pract Res Clin Gastroenterol (2005) 0.87
Surgical treatment of pancreatic endocrine tumours in Italy: results of a prospective multicentre study of 262 cases. Langenbecks Arch Surg (2010) 0.87
CagA and VacA are immunoblot markers of past Helicobacter pylori infection in atrophic body gastritis. Helicobacter (2007) 0.87